Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?! Thomas ThumJochen Springer Editorial Open access 21 September 2011 Pages: 121 - 123
The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? David ScottLeigh BlizzardGraeme Jones Review Open access 28 July 2011 Pages: 125 - 134
Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle Mariantonietta CicoiraStefan D. AnkerClaudio Ronco Review Open access 24 August 2011 Pages: 135 - 142
The role of myostatin in muscle wasting: an overview Yulia ElkinaStephan von HaehlingJochen Springer Review Open access 26 July 2011 Pages: 143 - 151
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial James T. DaltonKester G. BarnetteMitchell S. Steiner Original Article Open access 02 August 2011 Pages: 153 - 161
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia R. DallmannP. WeyermannA. Feurer Original Article Open access 28 August 2011 Pages: 163 - 174
Increased desmin expression in hindlimb muscles of aging rats David W. RussJessica S. Grandy Original Article Open access 07 July 2011 Pages: 175 - 180
Decreased NADPH oxidase expression and antioxidant activity in cachectic skeletal muscle Melanie J. Sullivan-GunnSiun P. Campbell-O’SullivanPaul A. Lewandowski Original Article Open access 11 August 2011 Pages: 181 - 188